Hyperliquid Strategies (NASDAQ:PURR – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at Chardan Capital in a note issued to investors on Thursday,Benzinga reports. They currently have a $9.75 price objective on the stock. Chardan Capital’s price objective would suggest a potential downside of 25.14% from the stock’s previous close.
A number of other research analysts have also recently commented on the stock. Cantor Fitzgerald boosted their target price on shares of Hyperliquid Strategies from $8.00 to $18.40 and gave the stock an “overweight” rating in a research report on Wednesday, July 1st. Weiss Ratings raised shares of Hyperliquid Strategies from a “sell (d)” rating to a “sell (d+)” rating in a research note on Wednesday, June 3rd. Three analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat.com, Hyperliquid Strategies presently has an average rating of “Moderate Buy” and an average target price of $12.72.
Get Our Latest Stock Analysis on Hyperliquid Strategies
Hyperliquid Strategies Stock Performance
Institutional Investors Weigh In On Hyperliquid Strategies
A number of institutional investors have recently modified their holdings of the stock. BlackRock Inc. acquired a new position in Hyperliquid Strategies in the second quarter worth about $79,842,000. Paradigm Operations LP acquired a new stake in Hyperliquid Strategies during the second quarter valued at approximately $44,936,535,000. Galaxy Group Investments LLC acquired a new stake in Hyperliquid Strategies during the fourth quarter valued at approximately $15,167,000. Pantera Capital Partners LP bought a new position in Hyperliquid Strategies during the 4th quarter worth approximately $14,545,000. Finally, Feynman Point Asset Management LLC bought a new position in Hyperliquid Strategies during the 4th quarter worth approximately $14,431,000. Institutional investors and hedge funds own 9.45% of the company’s stock.
Hyperliquid Strategies Company Profile
Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.
Further Reading
- Five stocks we like better than Hyperliquid Strategies
- Marvell’s Big AI Test Comes One Day After NVIDIA’s Blowout Quarter
- NVIDIA’s Blockbuster Quarter May Still Undersell How Big the AI Buildout Is
- Alphabet Is Building a Base—Could a Breakout Be Next?
- When Unusual Volume Isn’t Noise: 3 Small-Caps Sending Signals
Receive News & Ratings for Hyperliquid Strategies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperliquid Strategies and related companies with MarketBeat.com's FREE daily email newsletter.
